CA3165082A1 - Composition pour le traitement de trouble climaterique comprenant lactobacillus gasseri bnr17 - Google Patents

Composition pour le traitement de trouble climaterique comprenant lactobacillus gasseri bnr17 Download PDF

Info

Publication number
CA3165082A1
CA3165082A1 CA3165082A CA3165082A CA3165082A1 CA 3165082 A1 CA3165082 A1 CA 3165082A1 CA 3165082 A CA3165082 A CA 3165082A CA 3165082 A CA3165082 A CA 3165082A CA 3165082 A1 CA3165082 A1 CA 3165082A1
Authority
CA
Canada
Prior art keywords
amelioration
present
group
climacteric
bnr17
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3165082A
Other languages
English (en)
Inventor
Han-Oh Park
Myeong Hee Kim
Bong Jun Jung
Wonbeak YOO
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Acebiome Inc
Original Assignee
Acebiome Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acebiome Inc filed Critical Acebiome Inc
Publication of CA3165082A1 publication Critical patent/CA3165082A1/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/489—Sophora, e.g. necklacepod or mamani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Botany (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Reproductive Health (AREA)
  • Medical Informatics (AREA)
  • Endocrinology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La présente invention concerne une composition pharmaceutique pour le traitement d'un trouble climatérique, contenant Lactobacillus gasseri BNR17 comme principe actif, et une composition alimentaire fonctionnelle, pour prévenir ou atténuer des symptômes climatériques, contenant Lactobacillus gasseri BNR17 comme principe actif. Lactobacillus gasseri BNR17 selon la présente invention a un excellent effet sur le traitement, la prévention ou l'atténuation de divers symptômes climatériques, tels que l'atténuation de l'ostéoporose, qui est le symptôme représentatif du climatère, le soulagement de la dépression involutionnelle, l'atténuation de l'hypersensibilité à la douleur, et l'atténuation de la sécheresse vaginale.
CA3165082A 2020-02-17 2021-02-17 Composition pour le traitement de trouble climaterique comprenant lactobacillus gasseri bnr17 Pending CA3165082A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20200019129 2020-02-17
KR10-2020-0019129 2020-02-17
PCT/KR2021/002034 WO2021167350A1 (fr) 2020-02-17 2021-02-17 Composition pour le traitement de trouble climatérique comprenant lactobacillus gasseri bnr17

Publications (1)

Publication Number Publication Date
CA3165082A1 true CA3165082A1 (fr) 2021-08-26

Family

ID=77391458

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3165082A Pending CA3165082A1 (fr) 2020-02-17 2021-02-17 Composition pour le traitement de trouble climaterique comprenant lactobacillus gasseri bnr17

Country Status (8)

Country Link
US (1) US20230124145A1 (fr)
EP (1) EP4108249A4 (fr)
JP (1) JP7410336B2 (fr)
KR (2) KR102558595B1 (fr)
CN (1) CN115087453B (fr)
AU (1) AU2021224434B2 (fr)
CA (1) CA3165082A1 (fr)
WO (1) WO2021167350A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102587940B1 (ko) 2023-03-02 2023-10-11 주식회사 현대바이오랜드 에스트로겐 수용체 베타 특이적 활성화를 통한 여성 갱년기 증상의 예방 또는 치료 효능을 갖는 비피도박테리움 브레브 hdb7040 균주
CN116555129B (zh) * 2023-07-11 2023-09-29 北京量化健康科技有限公司 格氏乳杆菌bdup、其应用及产品
CN117736960B (zh) * 2024-02-21 2024-05-07 滨州医学院 一种小白链霉菌基因工程菌及其应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003252772A (ja) 2002-03-04 2003-09-10 Snow Brand Milk Prod Co Ltd 加齢に伴う代謝異常症の予防・改善・治療剤
KR20040038481A (ko) * 2002-11-01 2004-05-08 주식회사 렉스진바이오텍 천연물로부터 분리된 이소플라본 함유 추출물을 포함하는건강보조식품
KR100509682B1 (ko) 2003-11-26 2005-08-23 주식회사 렉스진바이오텍 괴각 추출물을 유효성분으로 함유하는 골 대사성 질환의 예방 및 치료용 약학적 조성물
WO2008016214A1 (fr) 2006-08-04 2008-02-07 Bioneer Corporation Bactérie d'acide lactique isolée à partir de lait maternel à activité probiotique et à activité inhibitrice dirigée contre l'augmentation du poids corporel
KR100943747B1 (ko) * 2006-11-29 2010-02-23 (주)바이오니아 락토바실러스 가세리 ｂｎｒ17 균주를 포함하는 당뇨병예방 및 치료용 조성물
US9283252B2 (en) 2008-09-30 2016-03-15 Meiji Co., Ltd. Lactic acid bacterium having high oxalic acid decomposition ability
KR20110004603A (ko) * 2009-07-08 2011-01-14 (주)노바셀테크놀로지 폐경기 질환의 치료 또는 예방, 피부 노화 방지, 또는 피부 주름 개선용 회화나무 추출물
JP5155961B2 (ja) 2009-07-17 2013-03-06 雪印メグミルク株式会社 加齢に伴う代謝異常症の予防・改善・治療剤
EP2428214A1 (fr) * 2010-09-14 2012-03-14 HSO Health Care GmbH Compositions pour l'administration vaginale et orale de lactobacillus et utilisations correspondantes
SG190719A1 (en) * 2010-11-29 2013-07-31 Meiji Co Ltd Endometriosis prevention and/or improving agent, and food or drink composition containing same
KR101279852B1 (ko) * 2011-06-29 2013-07-09 주식회사 쎌바이오텍 골다공증 예방 또는 치료용 조성물
JP5466268B2 (ja) 2012-06-15 2014-04-09 雪印メグミルク株式会社 加齢に伴う代謝異常症の予防・改善・治療剤
JP5765832B2 (ja) 2013-12-26 2015-08-19 雪印メグミルク株式会社 加齢に伴う代謝異常症の予防・改善・治療剤
KR102275268B1 (ko) * 2016-05-26 2021-07-09 주식회사 엘지생활건강 갱년기 증상 또는 골다공증 개선용 조성물
KR101964841B1 (ko) * 2017-03-07 2019-08-07 주식회사 엘지생활건강 여성 갱년기 증상 개선용 조성물

Also Published As

Publication number Publication date
KR102711333B1 (ko) 2024-09-30
KR20210104596A (ko) 2021-08-25
JP7410336B2 (ja) 2024-01-09
JP2023515275A (ja) 2023-04-12
CN115087453A (zh) 2022-09-20
US20230124145A1 (en) 2023-04-20
EP4108249A1 (fr) 2022-12-28
EP4108249A4 (fr) 2024-02-07
KR20230109598A (ko) 2023-07-20
AU2021224434A1 (en) 2022-07-28
KR102558595B1 (ko) 2023-07-25
CN115087453B (zh) 2024-08-09
WO2021167350A1 (fr) 2021-08-26
AU2021224434B2 (en) 2024-10-10

Similar Documents

Publication Publication Date Title
AU2021224434B2 (en) Composition for treating climacteric disorder comprising Lactobacillus gasseri BNR17
Rolim et al. Cheeses as food matrixes for probiotics: In vitro and in vivo tests
AU2008222007B2 (en) Agent for reducing visceral fat
TWI463986B (zh) 胚芽乳酸桿菌ｃｍｕ９９５菌株之新用途
EP2440217B1 (fr) Nutrition pour amélioration de la résistance musculaire des personnes âgées
JP2009511469A (ja) 脂肪代謝及び肥満に影響を及ぼすプロバイオティクス
KR101680014B1 (ko) 김치로부터 분리한 염증성 장 질환 치료 효과를 갖는 유산균
AU2007292786B2 (en) Agent for accelerating the increase in and/or preventing the decrease in blood adiponectin level, and visceral fat accumulation inhibitor
CN111372477B (zh) 在含有gos的培养基中预调理的益生菌及其用途
JP2019535828A (ja) ギ酸生成能に優れた菌株を有効成分として含む肥満または肥満によって惹起された代謝症候群の予防または治療用組成物
KR101545551B1 (ko) 인슐린 저항성 개선 효능을 갖는 7종의 유산균 복합균주를 유효성분으로 함유하는 조성물
WO2023066973A1 (fr) Souches probiotiques de réduction du cholestérol sanguin et/ou de traitement de la dyslipidémie, et procédés d'utilisation et de production de celles-ci
Saleem et al. Therapeutic potential of popular fermented dairy products and its benefits on human health
JP2013538827A (ja) 腎機能を増強させるための組成物および方法
JP5229977B2 (ja) 血中アディポネクチン濃度増加促進及び／又は減少抑制剤
KR101010913B1 (ko) 항고혈압활성 락토바실러스 플란타룸 및 이를 포함하는 발효물
US20090196867A1 (en) Soy kefir powder and uses thereof
JP2007126399A (ja) グルタチオン増加用組成物
CN117042761A (zh) 用于增强乳酸菌的生理功效的组合物
US20200069748A1 (en) Human-derived lactobacillus frementum mg4231 or lactobacillus frementum mg4244 strain having anti-obesity activity and composition comprising same
US11730779B2 (en) Lactic acid bacterial composition for treating or preventing jaundice
JP2024512621A (ja) 乳酸菌の生理活性効果増強用組成物
KR20230045340A (ko) 체지방을 감소시키거나 지방간 형성을 억제시키기 위한 열처리 락토바실러스 플란타룸 k8 조성물
JP2003252771A (ja) 加齢に伴う代謝異常疾患の予防・改善・治療剤
KR20230121587A (ko) 엔테로코커스 패칼리스, 이의 배양액 또는 이의 사균체를 유효성분으로 포함하는 지방간 예방 또는 치료용 조성물

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20220715

EEER Examination request

Effective date: 20220715

EEER Examination request

Effective date: 20220715

EEER Examination request

Effective date: 20220715

EEER Examination request

Effective date: 20220715

EEER Examination request

Effective date: 20220715